<?xml version="1.0" encoding="UTF-8"?>
<p>Several filgrastim products have been developed since the approval of the original product. In the European Union, starting from 2008, 9 filgrastim biosimilars were approved and 7 products are currently in use.
 <xref rid="b7-dddt-12-2381" ref-type="bibr">7</xref> In the USA, Sandoz Inc. (Princeton, NJ, USA) got approval of Zarxio
 <sup>Â®</sup>, which was the first biosimilar product passed through the US Food and Drug Administration (FDA) biosimilar approval pathway.
 <xref rid="b8-dddt-12-2381" ref-type="bibr">8</xref> In 2017, it is still the only biosimilar filgrastim product available in USA.
</p>
